Current Liabilities Изменить Дата
Agios Pharmaceuticals USD 67.96M 9.53M 2023-12
ALKERMES USD 503.11M 15.92M 2023-09
Alterity Therapeutics Limited AUD 4.38M 849.82K 2023-06
Amgen USD 18.39B 1.44B 2023-12
Baxter International USD 6.5B 294M 2023-12
Biogen USD 3.43B 1.59B 2023-12
Bluebird Bio USD 158.96M 23.94M 2023-09
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Cara Therapeutics USD 22.88M 2.58M 2023-09
Eisai JPY 307.31B 11.44B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Esperion Therapeutics USD 137.71M 30.54M 2023-09
Exelixis USD 376.82M 37.2M 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
GlaxoSmithKline GBP 22.39B 282M 2023-09
Grifols EUR 2.03B 148.07M 2023-09
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Incyte USD 1.24B 115.7M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Ironwood Pharmaceuticals USD 276.1M 4.48M 2023-12
Merck USD 23.09B 300M 2023-09
Nektar Therapeutics USD 52.11M 1.42M 2023-09
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
Roche Holding CHF 26.21B 1.03B 2023-06
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Takeda JPY 2.37T 134.12B 2023-09
Teva Pharmaceutical Industries USD 11.39B 449M 2023-09
Xencor USD 84.71M 31.67M 2023-12



Nektar Therapeutics Текущие Обязательства - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.